Coriolis Pharma
Business Services · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Fraunhoferstraße 18 b, Martinsried, Bava...Phone Number
+49 894177600Website
www.coriolis-pharma.comRevenue
$18.6 MillionIndustry
About Coriolis Pharma
Coriolis Pharma Org Chart
Director, Commercial Operations (US)
General Manager
Is Coriolis Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Coriolis Pharma recently announced quarterly report
Coriolis Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Coriolis Pharma
Product Launch: Get notified when Coriolis Pharma launches new products
Click to see if Coriolis Pharma had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Coriolis Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Coriolis Pharma is spiking on competitors!
Funding: Get notified immidiatlly once Coriolis Pharma has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Coriolis Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Coriolis Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Coriolis Pharma.
Coriolis Pharma Tech Stack
A closer look at the technologies used by Coriolis Pharma
Most Recent Scoops
Coriolis Pharma News & Media
Coriolis Pharma Appoints Peter Sölkner to Board of Directors to Support the Company's ...
Coriolis Pharma has appointed Peter Sölkner as a non-executive director. The appointment underscores Coriolis’ commitment to strengthening its board of directors and driving its strategic growth objectives.Coriolis Pharma launches U.S. entity alongside innovative drug product platform service offerings for monoclonal antibodies
New entity offers U.S. partners the convenience of local presence with the advantages of international expertise Novel developability assessment and pre-formulation platform services shorten time to market and de-risk drug product development projects MARTINSRIED-MUNICH, Germany, May 29,...SentrySciences Signs Collaboration Agreement with Coriolis Pharma
SentrySciences proudly announces a recent collaboration agreement with Coriolis Pharma. Within the scope of a pilot phase, Coriolis will act as the exclusive service provider for SentrySciences' ParticleSentryAI software analysis services in Europe. LONGMONT, Colo., May 7, 2024...KKR and Flerie Form Specialized Pharma Services Platform Frontier Biosolutions and Invest in Coriolis Pharma
MUNICH--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced, in partnership with Flerie, the formation of a new global pharma services platform, Frontier Biosolutions (“Frontier”), which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in the development and manufacturin
Top Business Services Companies
Frequently Asked Questions Regarding Coriolis Pharma
Coriolis Pharma is a premier drug product development company located in Martinsried, Germany, specializing in formulation and analytical services for biologics and complex pharmaceuticals. The company offers a comprehensive range of services including drug product development, analytical testing, and manufacturing, catering to various therapeutic... Read More